BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29851859)

  • 1. Nutritional prognostic scores in patients with hilar cholangiocarcinoma treated by percutaneous transhepatic biliary stenting combined with 125I seed intracavitary irradiation: A retrospective observational study.
    Cui P; Pang Q; Wang Y; Qian Z; Hu X; Wang W; Li Z; Zhou L; Man Z; Yang S; Jin H; Liu H
    Medicine (Baltimore); 2018 Jun; 97(22):e11000. PubMed ID: 29851859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with
    Hu X; Pang Q; Liu H; Qian Z; Jin H; Zhou L; Wang Y; Man Z; Li Z; Yang S
    Clin Transl Oncol; 2019 May; 21(5):665-673. PubMed ID: 30368724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary stenting alone versus biliary stenting combined with
    Pang Q; Zhou L; Hu XS; Wang Y; Man ZR; Yang S; Wang W; Qian Z; Jin H; Liu HC
    Sci Rep; 2019 Aug; 9(1):11348. PubMed ID: 31383886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
    Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of treatment methods and prognostic factors in 354 cases of hilar cholangiocarcinoma: A cohort study.
    Sun Z; Feng Y; Liu H; Shen F; Xiao J; Kang X; Zhao Y; Xiao H; Zhao W; Hu X; Li J; Ma H; Cao G; Su N; Zhang B
    J Cancer Res Ther; 2020; 16(2):230-237. PubMed ID: 32474506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PTCD-based biliary stent placement combined with 125I particle intracavitary irradiation in treating pancreatic head cancer.
    Cao J; Wang Z; Cai H; Zhang J; Yue Y; Liu X; Zhang D
    J BUON; 2020; 25(2):1056-1062. PubMed ID: 32521906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling Nutritional Status (CONUT) Score as a New Indicator of Prognosis in Patients With Hilar Cholangiocarcinoma Is Superior to NLR and PNI: A Single-Center Retrospective Study.
    Wang A; He Z; Cong P; Qu Y; Hu T; Cai Y; Sun B; Chen H; Fu W; Peng Y
    Front Oncol; 2020; 10():593452. PubMed ID: 33505910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of inflammation-based markers in patients with recurrent malignant obstructive jaundice treated by reimplantation of biliary metal stents: A retrospective observational study.
    Jin H; Pang Q; Liu H; Li Z; Wang Y; Lu Y; Zhou L; Pan H; Huang W
    Medicine (Baltimore); 2017 Jan; 96(3):e5895. PubMed ID: 28099348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival.
    Zhang XF; Beal EW; Merath K; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
    J Surg Oncol; 2018 May; 117(6):1267-1277. PubMed ID: 29205351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of the controlling nutritional status score and the prognostic nutritional index with the prognosis of patients treated with radiotherapy for small-cell lung cancer.
    Li L; Wang Y; Yang P; Xu L; Liu S; Zhang S; Weng X
    Ann Palliat Med; 2021 Nov; 10(11):11635-11642. PubMed ID: 34872288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2017 Feb; 161(2):394-404. PubMed ID: 27712872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Systemic Immune-Inflammation Index-Based Nomogram in Patients with Extrahepatic Cholangiocarcinoma Treated by Percutaneous Transhepatic Biliary Stenting Combined with
    Yang J; Shu C; Shang X; Xu H; Wei N
    Int J Gen Med; 2023; 16():2081-2094. PubMed ID: 37275332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of preoperative percutaneous transhepatic biliary drainage on surgical treatment of type Ⅲ and Ⅳ hilar cholangiocarcinoma].
    Wang DD; Xu JZ; Fu Q; Fu XJ; Chen FF; Lu Z; Guo J; Ma X; Sun WL; Zhang DY
    Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):288-292. PubMed ID: 30929375
    [No Abstract]   [Full Text] [Related]  

  • 16. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
    Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
    Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of malnutrition in patients with severely decompensated acute heart failure, as assessed using the Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) score.
    Shirakabe A; Hata N; Kobayashi N; Okazaki H; Matsushita M; Shibata Y; Nishigoori S; Uchiyama S; Asai K; Shimizu W
    Heart Vessels; 2018 Feb; 33(2):134-144. PubMed ID: 28803356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma.
    Wang Y; Cui W; Fan W; Zhang Y; Yao W; Huang K; Li J
    Oncotarget; 2016 Aug; 7(33):53911-53920. PubMed ID: 27322076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar Cholangiocarcinoma Resection.
    Yoo T; Park SJ; Han SS; Kim SH; Lee SD; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
    Cancer Res Treat; 2018 Oct; 50(4):1106-1113. PubMed ID: 29141394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.